Tolu Sena

Dr. Tolu Sena

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

26 November 2019 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
ISIsmihan Sunar
Ismihan Sunar
SASebnem Ataman
Sebnem Ataman
KNKemal Nas
Kemal Nas
EKErkan Kilic
Erkan Kilic
BSBetül Sargın
Betül Sargın
TTTiraje Tuncer
Tiraje Tuncer

31 December 2020 in Archives of Rheumatology
Verified
Journal Article
Open access
PDF file
TSTolu Sena
Tolu Sena
ARAylin Rezvani̇
Aylin Rezvani̇
IKİlHan Karacan
İlHan Karacan
DBDerya Bugdayci
Derya Bugdayci
HKHabib Can Küçük
Habib Can Küçük
TATeoman Aydin
Teoman Aydin
Objectives: This study aims to investigate medication adherence in Turkish patients with ankylosing spondylitis (AS) and analyze the related factors for non-adherence. Patients and methods: Ninety-nine patients with AS (60 males, 39 females; mean age 41.3±8.4 years; range, 18 to 66 years) were included in the study. Sociodemographic and clinical data were collected. Disease activity (Bath Ankylosing Spondylitis Disease Activity Index, C-reactive protein, and erythrocyte sedimentation rate), functional status (Bath Ankylosing Spondylitis Functional Index), spinal pain and fatigue (visual analog scale), quality of life (Ankylosing Spondylitis Quality of Life), and depression and anxiety (Hospital Anxiety and Depression Scale) were evaluated. Adherence to anti-rheumatic drugs was elicited using the Compliance Questionnaire on Rheumatology (CQR). Medication beliefs were assessed using the Beliefs about Medicines Questionnaire (BMQ), and illness perception using the Brief Illness Perception Questionnaire (B-IPQ). Results: Non-adherence was reported in 64 patients (64.6%). No significant relationship between demographic, clinical, or psychological factors and adherence was found, except for disease duration (p=0.031). High B-IPQ treatment follow-up, illness coherence, and BMQ-Specific necessity scores were associated with good adherence (p=0.007, p=0.039, and p=0.002, respectively). BMQ-General overuse and harm scores showed an inverse correlation with the CQR score (p=0.005 r=-0.278; p=0.029 r=-0.219, respectively). Longer disease duration [odds ratio (OR): 0.98, 95% confidence interval (CI): 0.97-0.99] and higher B-IPQ item-1 score regarding the effect of the illness on the individual's life (OR: 0.58, 95% CI: 0.42- 0.81) were important predictors of low adherence. Conclusion: Nearly three out of five AS patients were identified as at risk for non-adherence with the CQR. Medication adherence is influenced by the patient’s beliefs about medicines and illness perceptions, and these may be key targets for future interventions to improve medication adherence.

17 September 2020 in Modern Rheumatology
Verified
Journal Article
Closed access
KNKemal Nas
Kemal Nas
EKErkan Kiliç
Erkan Kiliç
İTİbrahim Tekeoğlu
İbrahim Tekeoğlu
YKYaşar Keskin
Yaşar Keskin
RÇRemzi Çevik
Remzi Çevik
HEHilal Ecesoy
Hilal Ecesoy
Objectives: In this study, we aimed to evaluate the effect of gender on clinical findings, disease activity, functional status and quality of life in patients with axial involvement in Turkey. Methods: Patients with PsA who met the CASPAR classification criteria were enrolled consequently in this cohort. Turkish League Against Rheumatism (TLAR)-Network was formed with the participation of 25 centres. The demographic variables, fatigue, diagnostic delay, the beginning of peripheral arthritis, enthesitis, dactylitis and spine involvement, inflammatory low back pain, BASFI, HAQ, HAQ-s, visual analog scale-pain (VAS-pain), anxiety, depression and disease activity parameters (ESR, DAS28, BASDAI) were recorded. Axial involvement was assessed according to clinical and radiological data according to modified New York (MNYC) or SpondyloArthritis International Society Assessment (ASAS) criteria (AC). Results: A total of 1018 patients with PsA were included in this study. Of the 373 patients with axial involvement, 150 were male (40.2%) and 223 (59.8%) were female. Spondylitis was detected in 14,7% of men and 21,9% of women in all patients. Pain score (VAS) (p< 0,002), fatigue (p <0.001), ESR (p <0.001), DAS28 (p <0.001), BASDAI score (p <0.001), PsAQoL (p <0.001), HAQ score (p < 0,01), HAQ-S score (p< 0.001), anxiety (p <0.001), depression (p < 0,024), FACIT (p <0.001) and FiRST (p <0.001) scores were statistically significantly worse in women than males with axial PsA. However, quality of life was better (p <0.001) and PASI score (p< 0.005) were statistically worse in male patients than in female patients with axial involvement. Conclusion: This study has shown that the burden of disease in axial PsA has significant difference between genders. Disease activity, physical disability, functional limitation, depression and anxiety scores were higher in female patients, while quality of life were better and PASI score were higher in male patients. Therefore, we suggest that new strategies should be developed for more effective treatment of axial PsA in female patients.

28 August 2021 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
KGKevser Gok
Kevser Gok
KNKemal Nas
Kemal Nas
ITIbrahim Tekeoglu
Ibrahim Tekeoglu
ISIsmihan Sunar
Ismihan Sunar
YKYasar Keskin
Yasar Keskin
TTTiraje Tuncer
Tiraje Tuncer

15 August 2022 in European Journal of Cancer Care
Verified
Journal Article
Closed access
SGSelen Güloğlu
Selen Güloğlu
YÖYunus Özdemir
Yunus Özdemir
PBPelin Basim
Pelin Basim
TSTolu Sena
Tolu Sena